Skip to main content
Erschienen in: Oral and Maxillofacial Surgery 3/2011

Open Access 01.09.2011 | Case Report

A rare association: basal cell carcinoma in a vitiliginous macula

verfasst von: Jan Rustemeyer, Lutz Günther, Linda Deichert

Erschienen in: Oral and Maxillofacial Surgery | Ausgabe 3/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Today, no proven significant association was detected between sun-exposed vitiliginous patches and non-melanotic skin cancers. In fact, the occurrence of a basal cell carcinoma (BCC) in vitiliginous patches seems to be extremely rare.

Case report

We present a case of a 33-year-old female patient suffering from BCC in a vitiliginous patch on the cheek. This is the first report of the occurrence of a sclerodermiform type of BCC in a vitiliginous macula.

Conclusion

Our case report challenges the long-standing belief that the occurrence of BCC in vitiligo is nearly impossible. However, even if this association is apparently fortuitous, our report contributes to the awareness of the risk of BCC in young patients with vitiligo.

Introduction

The possible association of vitiligo and non-melanotic skin cancers (NMSC) has been discussed controversially and no consensus had been achieved in the literature as to whether this association is significant or fortuitous. Few reports of occurrences of squamous cell carcinoma in patients with generalized vitiligo or after long-term psoralen ultraviolet-A therapy for vitiligo had been published previously [13]; basal cell carcinoma (BCC) in vitiliginous patches seems to be rare. Hence, reports could be found in recent literature only sporadically [4]. We present a case report of a young female suffering from BCC appearing on vitiligo macula in the cheek region and a review of the recent literature. To our knowledge, this is the first report of a sclerodermiform type of BCC associated with vitiligo. It is also important to note the young age of the patient.

Case report

A 33-year-old Caucasian female was referred from the department of dermatology to the oral and maxillofacial department at our clinic centre. When the patient first presented, a 5 × 3.5-cm, erythematous, partly verrucous, partly plain and not well-circumscribed lesion located on a 6 × 4.5 depigmented vitiliginous patch on the left cheek was found (Fig. 1). This lesion had been present for 5 years and the patient had sought no treatment. No further depigmented patches on the body surface could be detected. The patient denied excessive sun exposure or sunburns in the past. A biopsy was performed and histological evaluation revealed a sclerodermiform BCC (Fig. 2). The total resection of the tumour included the resection of the whole vitiligo patch. Histological evaluation showed complete excision of the tumour with an infiltration depth of 7 mm and circumferential and basal security borders of 3 mm. Following clarification about plastic reconstruction possibilities, the patient preferred a split-thickness skin graft reconstruction with skin from a femoral donor site. After resection, the defect was temporarily covered with artificial skin substitute for 14 days until the tissue had nearly reached the level of the surrounding skin. In a second step, the defect was closed with a 4-mm split-thickness skin graft from the right femoral region. As expected, a difference in colour occurred towards the surrounding tissue after 5 weeks (Fig. 3). However, the patient was completely satisfied with the outcome.

Discussion

Ultraviolet radiation is a well-known risk factor in Caucasians for developing BCC with a latency period of decades. Considering that patients with vitiligo often have no protective pigment in sun-exposed vitiliginous skin areas, it would be expected that these patients have an increased risk for early photodamage and development of NMSC. Until now, however, there was no evidence found for sun-related damage in these patients histologically or by dermatoscopy. This was despite a significant number of cases with a history of sunburns in early childhood and continuous accumulation of millimolar epidermal peroxide [2]. Interestingly, this lack of sun-related damages could be linked to an overexpression of functional wild-type tumour suppressor gene p53 in vitiligo patches. This proposes that there is a protective function of this tumour suppressor gene in vitiligo, which could avoid lasting photodamage and the development of NMSC [5]. However, these findings are in contradiction to the occurrences of squamous cell carcinoma on a localized lesion of vitiligo, which has never been exposed to sunlight, e.g., on the genital mucous membrane [6], and the development of BCC in our case report.
Generally, in patients with vitiligo, it has to be determined whether the skin cancers were located on vitiliginous or normal-appearing skin. Hexel et al. [7] reported about six Caucasian patients with NMSC and vitiligo on sun-exposed sites. In only two patients NMSC occurred on the skin of the face. In only one of these patients BCC occurred on vitiliginous skin of the nasolabial fold and in the other patient in the normal preauricular skin. Both patients were male and older than 75 years. In this study, the incidence of NMSC among Caucasian patients with vitiligo was compared with cohorts from age-adjusted US populations. Results suggest that there may be an increased or equal risk of NMSC in patients with vitiligo. However, significant differences could not be obtained in comparison to patients without vitiligo. In our case report, the patient represented Fitzpatrick skin phototype II [8] and was therefore more susceptible to skin cancer. Although the patient was young, the localization in a vitiliginous patch and the low sun exposure are in contrast to the usual risk factors for BCC. Obviously, other factors, such as spontaneous mutations on the genetic level [9], might play a more important role. Further studies with large cohorts providing histological as well as immunohistochemical findings are warranted to enlighten the relationship between vitiligo and NMSC. Our case report contributes to the awareness of the risk of developing BCC even in young patients with vitiligo.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Literatur
1.
Zurück zum Zitat Seo Sl, Kim IH (2001) Squamous cell carcinoma in a patient with generalized vitiligo. J Am Acad Dermatol 45:227–229CrossRef Seo Sl, Kim IH (2001) Squamous cell carcinoma in a patient with generalized vitiligo. J Am Acad Dermatol 45:227–229CrossRef
2.
Zurück zum Zitat Schallreuter KU, Tobin DJ, Panske A (2002) Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 204:194–201PubMedCrossRef Schallreuter KU, Tobin DJ, Panske A (2002) Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 204:194–201PubMedCrossRef
3.
Zurück zum Zitat Park HS, Lee YS, Chun DK (2003) Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. J Eur Acad Dermatol Venereol 17:578–580PubMedCrossRef Park HS, Lee YS, Chun DK (2003) Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. J Eur Acad Dermatol Venereol 17:578–580PubMedCrossRef
4.
Zurück zum Zitat Arnon O, Mamelak AJ, Goldberg LH (2008) Basal cell carcinoma arising in a patient with vitiligo. J Drugs Dermatol 7:1075–1076PubMed Arnon O, Mamelak AJ, Goldberg LH (2008) Basal cell carcinoma arising in a patient with vitiligo. J Drugs Dermatol 7:1075–1076PubMed
5.
Zurück zum Zitat Schallreuter KU, Behrens-Williams S, Khalip TP, Picksley SM, Peters EM, Marles LK, Westerhof W, Miehe B, Fanghänel J (2003) Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol 12:268–277PubMedCrossRef Schallreuter KU, Behrens-Williams S, Khalip TP, Picksley SM, Peters EM, Marles LK, Westerhof W, Miehe B, Fanghänel J (2003) Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol 12:268–277PubMedCrossRef
6.
Zurück zum Zitat Ravi S, Ramesh V, Misra RS (1990) Squamous cell carcinoma on a patch of mucosal vitiligo. Indian J Dermatol Venereol Leprol 56:64–65 Ravi S, Ramesh V, Misra RS (1990) Squamous cell carcinoma on a patch of mucosal vitiligo. Indian J Dermatol Venereol Leprol 56:64–65
7.
Zurück zum Zitat Hexsel CL, Eide MJ, Johnson CC, Krajenta R, Jacobsen G, Hamzavi I, Lim HW (2009) Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo. J Am Acad Dermatol 60:929–933PubMedCrossRef Hexsel CL, Eide MJ, Johnson CC, Krajenta R, Jacobsen G, Hamzavi I, Lim HW (2009) Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo. J Am Acad Dermatol 60:929–933PubMedCrossRef
8.
9.
Zurück zum Zitat Prior SL, Griffiths AP, Lewis PD (2009) A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. Br J Dermatol 161:1067–1071PubMedCrossRef Prior SL, Griffiths AP, Lewis PD (2009) A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer. Br J Dermatol 161:1067–1071PubMedCrossRef
Metadaten
Titel
A rare association: basal cell carcinoma in a vitiliginous macula
verfasst von
Jan Rustemeyer
Lutz Günther
Linda Deichert
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Oral and Maxillofacial Surgery / Ausgabe 3/2011
Print ISSN: 1865-1550
Elektronische ISSN: 1865-1569
DOI
https://doi.org/10.1007/s10006-010-0240-y

Weitere Artikel der Ausgabe 3/2011

Oral and Maxillofacial Surgery 3/2011 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.